Abstract A054: Comparative efficacy analysis of the polyisoprenylated cysteinyl amide inhibitor and sotorasib in lung cancer NCI-H23 mutant cell models
Lung Cancer remains the leading cause of cancer-related deaths worldwide, with African Americans experiencing the highest incidence and mortality rates compared to other ancestry-related groups in the United States. KRAS mutations account for approximately 30% of all cases. While KRASG12C inhibitor Sotorasib shows ef...